SynthesisBMJ open2021

Comparative efficacy and safety of different regimens of ranibizumab for neovascular age-related macular degeneration: a network meta-analysis of randomised controlled trials.

Xinyu Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.